Mc Ilrath & Eck, LLC Cybin Inc. Transaction History
Mc Ilrath & Eck, LLC
- $493 Million
- Q1 2024
A detailed history of Mc Ilrath & Eck, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 400 shares of CYBN stock, worth $104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$104
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CYBN
# of Institutions
109Shares Held
243MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$15.1 Million0.79% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$10.4 Million1.53% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$9.07 Million0.55% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$6.65 Million1.64% of portfolio
-
Octagon Capital Advisors LP New York, NY18.6MShares$4.84 Million1.19% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $43.2M
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...